Klaminder J, Brodin T, Sundelin A, Anderson N, Fahlman J, Jonsson M, et al. Long-Term Persistence of an Anxiolytic Drug (Oxazepam) in a Large Freshwater Lake. Environ Sci Technol. 2015;49:10406-12 pubmed publisher

Battal D, Barnes A, Castaneto M, Martin T, Klette K, Huestis M. Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry. Ther Drug Monit. 2015;37:805-11 pubmed publisher

Xiong L, Wang R, Liang C, Teng X, Jiang F, Zeng L, et al. Determination of co-administrated opioids and benzodiazepines in urine using column-switching solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2015;1395:99-108 pubmed publisher

Thompson T, Grabowski Boase L, Tarantino L. Prototypical anxiolytics do not reduce anxiety-like behavior in the open field in C57BL/6J mice. Pharmacol Biochem Behav. 2015;133:7-17 pubmed publisher

Mimura H, Kobayashi K, Xu L, Hashimoto M, Ejiri Y, Hosoda M, et al. Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4. Drug Metab Pharmacokinet. 2015;30:105-10 pubmed publisher

Stephanson N, Sandqvist S, Lambert M, Beck O. Method validation and application of a liquid chromatography-tandem mass spectrometry method for drugs of abuse testing in exhaled breath. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;985:189-96 pubmed publisher

Shayesteh T, Radmehr M, Khajavi F, Mahjub R. Application of chemometrics in determination of the acid dissociation constants (pKa) of several benzodiazepine derivatives as poorly soluble drugs in the presence of ionic surfactants. Eur J Pharm Sci. 2015;69:44-50 pubmed publisher

Sempio C, Morini L, Vignali C, Groppi A. Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC-MS/MS: application on postmortem samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;970:1-7 pubmed publisher

Bertol E, Mari F, Boscolo Berto R, Mannaioni G, Vaiano F, Favretto D. A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: determination of MDPV metabolites by LC-HRMS and discussion of the case. Forensic Sci Int. 2014;243:149-55 pubmed publisher

De Vrieze M, Verzele D, Szucs R, Sandra P, Lynen F. Evaluation of sphingomyelin, cholester, and phosphatidylcholine-based immobilized artificial membrane liquid chromatography to predict drug penetration across the blood-brain barrier. Anal Bioanal Chem. 2014;406:6179-88 pubmed publisher

Beck O, Carlsson S, Tusic M, Olsson R, Franzen L, Hultén P. Laboratory and clinical evaluation of on-site urine drug testing. Scand J Clin Lab Invest. 2014;74:681-6 pubmed publisher

Carlier J, Romeuf L, Guitton J, Priez Barallon C, Bevalot F, Fanton L, et al. A validated method for quantifying atractyloside and carboxyatractyloside in blood by HPLC-HRMS/MS, a non-fatal case of intoxication with Atractylis gummifera L. J Anal Toxicol. 2014;38:619-27 pubmed publisher

Maublanc J, Dulaurent S, Morichon J, Lachâtre G, Gaulier J. Identification and quantification of 35 psychotropic drugs and metabolites in hair by LC-MS/MS: application in forensic toxicology. Int J Legal Med. 2015;129:259-68 pubmed publisher

Fisher J, Taori G, Braitberg G, Graudins A. Methylene blue used in the treatment of refractory shock resulting from drug poisoning. Clin Toxicol (Phila). 2014;52:63-5 pubmed publisher

Brodin T, Fick J, Jonsson M, Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science. 2013;339:814-5 pubmed publisher

Ganji M, Nashtahosseini M, Yeganegi S, Rezvani M. First-principles vdW-DF investigation on the interaction between the oxazepam molecule and C₆₀ fullerene. J Mol Model. 2013;19:1929-36 pubmed publisher

Sarris J, Laporte E, Scholey A, King R, Pipingas A, Schweitzer I, et al. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study. Traffic Inj Prev. 2013;14:13-7 pubmed publisher

Flodin P, Gospic K, Petrovic P, Fransson P. Effects of L-dopa and oxazepam on resting-state functional magnetic resonance imaging connectivity: a randomized, cross-sectional placebo study. Brain Connect. 2012;2:246-53 pubmed publisher

Marin S, Roberts M, Wood M, McMillin G. Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma. J Anal Toxicol. 2012;36:472-6 pubmed publisher

Bailes J, Mayoss S, Teale P, Soloviev M. Gold nanoparticle antibody conjugates for use in competitive lateral flow assays. Methods Mol Biol. 2012;906:45-55 pubmed publisher

Goeders N, Cohen A, Fox B, Azar M, George O, Koob G. Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats. Psychopharmacology (Berl). 2012;223:17-25 pubmed publisher

Chang Q, Ma H, Wang F, Ou H, Zou M. [Determination of 10 sedative-hypnotics in human plasma using pulse splitless injection technique and gas chromatography-mass spectrometry]. Se Pu. 2011;29:1082-6 pubmed

Sarris J, Scholey A, Schweitzer I, Bousman C, Laporte E, Ng C, et al. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. Hum Psychopharmacol. 2012;27:262-9 pubmed publisher

Naggar A, ElKaoutit M, Naranjo Rodriguez I, El Sayed A, de Cisneros J. Use of a Sonogel-Carbon electrode modified with bentonite for the determination of diazepam and chlordiazepoxide hydrochloride in tablets and their metabolite oxazepam in urine. Talanta. 2012;89:448-54 pubmed publisher

Kablinger A, Lindner M, Casso S, Hefti F, Demuth G, Fox B, et al. Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study. J Psychopharmacol. 2012;26:973-81 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Kosjek T, Perko S, Zupanc M, Zanoški Hren M, Landeka Dragicević T, Zigon D, et al. Environmental occurrence, fate and transformation of benzodiazepines in water treatment. Water Res. 2012;46:355-68 pubmed publisher

Kukanich B, Nauss J. Pharmacokinetics of the cytochrome P-450 substrates phenytoin, theophylline, and diazepam in healthy Greyhound dogs. J Vet Pharmacol Ther. 2012;35:275-81 pubmed publisher

Chin P, Jensen B, Larsen H, Begg E. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol. 2011;72:985-9 pubmed publisher

Franck M, Foulon V, Van Vaerenbergh L. ABOP, the automatic patient information leaflet optimizer: evaluation of a tool in development. Patient Educ Couns. 2011;83:411-6 pubmed publisher

Gospic K, Mohlin E, Fransson P, Petrovic P, Johannesson M, Ingvar M. Limbic justice--amygdala involvement in immediate rejection in the Ultimatum Game. PLoS Biol. 2011;9:e1001054 pubmed publisher

Larsen H, Chin P, Begg E, Jensen B. Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS. Bioanalysis. 2011;3:843-52 pubmed publisher

Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda Lucena A. QSAR-based permeability model for drug-like compounds. Bioorg Med Chem. 2011;19:2615-24 pubmed publisher

Uzun S, Kozumplik O. Reinforcement of irritability during therapy with benzodiazepines. Psychiatr Danub. 2011;23:129-30 pubmed

Sabljić V, Rakun R, Ružić K, Grahovac T. Duloxetine-related panic attacks. Psychiatr Danub. 2011;23:114-6 pubmed

Tabrizi A, Harasi M. Applying cloud point extraction technique for the extraction of oxazepam from human urine as a colour or fluorescent derivative prior to spectroscopic analysis methods. Drug Test Anal. 2012;4:145-50 pubmed publisher

Hellrup J, Mahlin D. Pharmaceutical micro-particles give amorphous sucrose higher physical stability. Int J Pharm. 2011;409:96-103 pubmed publisher

Lusthof K, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong A. A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int. 2011;206:e93-5 pubmed publisher

Musulin S, Mariani C, Papich M. Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs. J Vet Pharmacol Ther. 2011;34:17-24 pubmed publisher

Olofsson J, Gospic K, Petrovic P, Ingvar M, Wiens S. Effects of oxazepam on affective perception, recognition, and event-related potentials. Psychopharmacology (Berl). 2011;215:301-9 pubmed publisher

Lahousse S, Hoenerhoff M, Collins J, Ton T, Masinde T, Olson D, et al. Gene expression and mutation assessment provide clues of genetic and epigenetic mechanisms in liver tumors of oxazepam-exposed mice. Vet Pathol. 2011;48:875-84 pubmed publisher

Prado Prado F, Garcia Mera X, González Díaz H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg Med Chem. 2010;18:2225-2231 pubmed publisher

Varma M, Obach R, Rotter C, Miller H, Chang G, Steyn S, et al. Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem. 2010;53:1098-108 pubmed publisher

Guerra A, Campillo N, Paez J. Neural computational prediction of oral drug absorption based on CODES 2D descriptors. Eur J Med Chem. 2010;45:930-40 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, et al. Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. Eur J Med Chem. 2009;44:4455-60 pubmed publisher

Varma M, Feng B, Obach R, Troutman M, Chupka J, Miller H, et al. Physicochemical determinants of human renal clearance. J Med Chem. 2009;52:4844-52 pubmed publisher

Li H, Sun J, Sui X, Liu J, Yan Z, Liu X, et al. First-principle, structure-based prediction of hepatic metabolic clearance values in human. Eur J Med Chem. 2009;44:1600-6 pubmed publisher

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Obach R, Lombardo F, Waters N. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36:1385-405 pubmed publisher

Wassvik C, Holmén A, Draheim R, Artursson P, Bergström C. Molecular characteristics for solid-state limited solubility. J Med Chem. 2008;51:3035-9 pubmed publisher

Lazaro E, Lowe P, Briand X, Faller B. New approach to measure protein binding based on a parallel artificial membrane assay and human serum albumin. J Med Chem. 2008;51:2009-17 pubmed publisher

Du Cuny L, Huwyler J, Wiese M, Kansy M. Computational aqueous solubility prediction for drug-like compounds in congeneric series. Eur J Med Chem. 2008;43:501-12 pubmed

Ottaviani G, Martel S, Carrupt P. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities. J Med Chem. 2007;50:742-8 pubmed

Caron G, Ermondi G. Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). J Med Chem. 2005;48:3269-79 pubmed

Kiang T, Ensom M, Chang T. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther. 2005;106:97-132 pubmed

Larsen J, Arnberg A, Brøsen K. [Tramadol and oxazepam. Effect on pulmonry function in elderly patients with chronic obstructive lung disease]. Ugeskr Laeger. 2001;163:458-60 pubmed

Olivier B, Molewijk E, van Oorschot R, Van der Heyden J, Ronken E, Mos J. Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands. Eur J Pharmacol. 1998;358:117-28 pubmed

Jing X, Wala E, Sloan J. The effect of chronic benzodiazepines exposure on body weight in rats. Pharmacol Res. 1998;37:179-89 pubmed

. Oxazepam. IARC Monogr Eval Carcinog Risks Hum. 1996;66:115-42 pubmed

Laviola G. On mouse pups and their lactating dams: behavioral consequences of early exposure to oxazepam and interacting factors. Pharmacol Biochem Behav. 1996;55:459-74 pubmed

Sonne J. Factors and conditions affecting the glucuronidation of oxazepam. Pharmacol Toxicol. 1993;73 Suppl 1:1-23 pubmed

Greenblatt D. Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet. 1981;6:89-105 pubmed

Kitani K, Klotz U, Kanai S, Sato Y, Ohta M, Nokubo M. Age-related differences in the coordination disturbance and anticonvulsant effect of oxazepam in mice. Arch Gerontol Geriatr. 1989;9:31-43 pubmed

Ayd F. Oxazepam: update 1989. Int Clin Psychopharmacol. 1990;5:1-15 pubmed

Greenblatt D, Shader R, Koch Weser J. Pharmacokinetics in clinical medicine: oxazepam versus other benzodiazepines. Dis Nerv Syst. 1975;36:6-13 pubmed

Blackwell B. A critical review of oxazepam: efficacy and specificity. Dis Nerv Syst. 1975;36:17-22 pubmed